These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33456444)

  • 1. Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease.
    Rahman MH; Akter R; Bhattacharya T; Abdel-Daim MM; Alkahtani S; Arafah MW; Al-Johani NS; Alhoshani NM; Alkeraishan N; Alhenaky A; Abd-Elkader OH; El-Seedi HR; Kaushik D; Mittal V
    Front Pharmacol; 2020; 11():619024. PubMed ID: 33456444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol as a therapeutic agent for Alzheimer's disease.
    Ma T; Tan MS; Yu JT; Tan L
    Biomed Res Int; 2014; 2014():350516. PubMed ID: 25525597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer's disease from bench to bedside.
    Islam F; Nafady MH; Islam MR; Saha S; Rashid S; Akter A; Or-Rashid MH; Akhtar MF; Perveen A; Md Ashraf G; Rahman MH; Hussein Sweilam S
    Mol Neurobiol; 2022 Jul; 59(7):4384-4404. PubMed ID: 35545730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol, a neuroprotective supplement for Alzheimer's disease.
    Li F; Gong Q; Dong H; Shi J
    Curr Pharm Des; 2012; 18(1):27-33. PubMed ID: 22211686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol and Amyloid-Beta: Mechanistic Insights.
    Jia Y; Wang N; Liu X
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 29036903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.
    Marambaud P; Zhao H; Davies P
    J Biol Chem; 2005 Nov; 280(45):37377-82. PubMed ID: 16162502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer's Disease.
    Braidy N; Jugder BE; Poljak A; Jayasena T; Mansour H; Nabavi SM; Sachdev P; Grant R
    Curr Top Med Chem; 2016; 16(17):1951-60. PubMed ID: 26845555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective Mechanisms of Resveratrol in Alzheimer's Disease: Role of SIRT1.
    Gomes BAQ; Silva JPB; Romeiro CFR; Dos Santos SM; Rodrigues CA; Gonçalves PR; Sakai JT; Mendes PFS; Varela ELP; Monteiro MC
    Oxid Med Cell Longev; 2018; 2018():8152373. PubMed ID: 30510627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective Effect of Resveratrol via Activation of Sirt1 Signaling in a Rat Model of Combined Diabetes and Alzheimer's Disease.
    Ma X; Sun Z; Han X; Li S; Jiang X; Chen S; Zhang J; Lu H
    Front Neurosci; 2019; 13():1400. PubMed ID: 32038127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced inflammation and oxidative stress.
    Chiang MC; Nicol CJ; Cheng YC
    Neurochem Int; 2018 May; 115():1-10. PubMed ID: 28989083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease.
    Porquet D; Griñán-Ferré C; Ferrer I; Camins A; Sanfeliu C; Del Valle J; Pallàs M
    J Alzheimers Dis; 2014; 42(4):1209-20. PubMed ID: 25024312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of resveratrol in Alzheimer disease pathology.
    Rege SD; Geetha T; Griffin GD; Broderick TL; Babu JR
    Front Aging Neurosci; 2014; 6():218. PubMed ID: 25309423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective Properties of Resveratrol and Its Derivatives-Influence on Potential Mechanisms Leading to the Development of Alzheimer's Disease.
    Wiciński M; Domanowska A; Wódkiewicz E; Malinowski B
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol protects β amyloid-induced oxidative damage and memory associated proteins in H19-7 hippocampal neuronal cells.
    Rege SD; Geetha T; Broderick TL; Babu JR
    Curr Alzheimer Res; 2015; 12(2):147-56. PubMed ID: 25654502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
    Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
    Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide.
    Colin J; Allouche A; Chauveau F; Corbier C; Pauron-Gregory L; Lanhers MC; Claudepierre T; Yen FT; Oster T; Malaplate-Armand C
    J Alzheimers Dis; 2016 May; 52(3):975-87. PubMed ID: 27163806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.